Terms: = Uterine cancer AND BRIP1, MGC126521, 83990, ENSG00000136492, FANCJ, FLJ90232, Q9BX63, MGC126523, OF AND Clinical Outcome
7 results:
1. outcomes and cost comparisons after introducing a robotics program for endometrial cancer surgery.
Lau S; Vaknin Z; Ramana-Kumar AV; Halliday D; Franco EL; Gotlieb WH
Obstet Gynecol; 2012 Apr; 119(4):717-24. PubMed ID: 22433334
[TBL] [Abstract] [Full Text] [Related]
2. Molecule-targeted agents in endometrial cancer.
Delmonte A; Sessa C
Curr Opin Oncol; 2008 Sep; 20(5):554-9. PubMed ID: 19106660
[TBL] [Abstract] [Full Text] [Related]
3. Laparoscopic occlusion compared with embolization of uterine vessels: a randomized controlled trial.
Hald K; Kløw NE; Qvigstad E; Istre O
Obstet Gynecol; 2007 Jan; 109(1):20-7. PubMed ID: 17197583
[TBL] [Abstract] [Full Text] [Related]
4. Dynamics of cervical langerhans cell counts in the course of HPV-positive CIN treatment with the use of human recombinant interferon gamma.
Sikorski M; Bieda T; Bobek M; Zrubek H
Eur J Gynaecol Oncol; 2005; 26(3):294-8. PubMed ID: 15991530
[TBL] [Abstract] [Full Text] [Related]
5. Vaccination strategies for the treatment and prevention of cervical cancer.
Schreckenberger C; Kaufmann AM
Curr Opin Oncol; 2004 Sep; 16(5):485-91. PubMed ID: 15314520
[TBL] [Abstract] [Full Text] [Related]
6. The clinical outcome of patients with stage Ia1 and Ia2 squamous cell carcinoma of the uterine cervix: a Cooperation Task Force (CTF) study.
Gadducci A; Sartori E; Maggino T; Landoni F; Zola P; Cosio S; Pasinetti B; Alessi C; Maneo A; Ferrero A
Eur J Gynaecol Oncol; 2003; 24(6):513-6. PubMed ID: 14658592
[TBL] [Abstract] [Full Text] [Related]
7. The prognostic relevance of histological type in uterine sarcomas: a Cooperation Task Force (CTF) multivariate analysis of 249 cases.
Gadducci A; Sartori E; Landoni F; Zola P; Maggino T; Cosio S; Tisi G; Lissoni A; Ferrero AM; Cristofani R
Eur J Gynaecol Oncol; 2002; 23(4):295-9. PubMed ID: 12214727
[TBL] [Abstract] [Full Text] [Related]
